Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buagafuran and Voriconazole DDI Study
NCT07457203Phase 1Not yet recruiting
- Sponsor
- Beijing Union Pharmaceutical Factory
- Start
- Apr 2026
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of buagafuran in anxiety disorder, sponsored by Beijing Union Pharmaceutical Factory. Primary endpoints: Maximum Plasma Concentration of Buagafuran, Area Under the Curve from time zero to infinity of Buagafuran and 1 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
buagafuran
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT07457203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07457203.